$GENI Income Statement | Understand Stock

$GENI

$6.32 -$0.20 (3.07%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Cost of revenue
Gross profit
Operating expenses:
Sales and marketing
Research and development
General and administrative
Transaction expenses
Total operating expenses
Loss from operations
Interest (expense) income, net
Gain (loss) on disposal of assets
Gain (loss) on fair value remeasurement of contingent consideration
Change in fair value of derivative warrant liabilities
Loss on abandonment of assets
Gain (loss) on foreign currency
Total other income (expense)
Loss before income taxes
Income tax benefit (expense)
Gain from equity method investment
Net loss
Preferred share accretion
Net loss attributable to common stockholders, basic
Loss per share attributable to common stockholders:
Basic
Diluted
Weighted average common stock outstanding:
Basic and diluted
Basic
Diluted

Comments